ResMed
ResMed is a global leader in sleep and respiratory care, with a major presence in the anti-snoring market, primarily through its solutions for Obstructive Sleep Apnea (OSA), which is a key cause of chronic snoring. The company’s Sleep and Respiratory Care business segment, which encompasses anti-snoring devices, is a significant revenue driver, highlighting its market dominance. While ResMed is most recognized for its Continuous Positive Airway Pressure (CPAP) machines, masks, and cloud-based digital health platforms like DreamMapper, their technology is fundamental to treating the underlying airway issues that cause snoring. They focus on continuous innovation in comfortable respiratory interfaces and data-driven adherence solutions. ResMed’s extensive product portfolio and technological expertise position it at the forefront of providing both professional and consumer-grade infrastructure for managing sleep-disordered breathing globally.
Latest Market Research Report on Anti-snoring Devices Download PDF Brochure Now
SomnoMed
SomnoMed is a leading global supplier of oral sleep apnea and anti-snoring devices, operating across 28 countries. The Australian-based company specializes in high-quality, custom-fitted mandibular advancement devices (MADs), such as the SomnoDent® Herbst Advance and SomnoDent Avant. These oral appliances are designed to gently move the jaw and tongue forward during sleep, effectively opening the airway to prevent snoring and treat mild-to-moderate Obstructive Sleep Apnea (OSA). SomnoMed is a key player, accounting for the second-largest market share in 2023, owing to its focus on patient comfort, notably through its proprietary b-flex Comfort Liner® technology. The company actively partners with dentists and sleep physicians to position its devices as a highly effective and patient-preferred alternative to CPAP therapy, demonstrating its commitment to transforming lives with better sleep solutions.
ProSomnus Sleep Technologies
ProSomnus Sleep Technologies is a major U.S.-based player in the anti-snoring devices market, specializing in the development and manufacturing of precise, custom-fitted intraoral medical devices for the treatment of mild-to-moderate Obstructive Sleep Apnea (OSA) and chronic snoring. The company utilizes a proprietary, highly automated manufacturing process, which includes AI-assisted design and robotic manufacturing, to produce advanced devices like the ProSomnus EVO®. These 3D-milled appliances are made from medical-grade plastic, prioritizing a comfortable, less bulky, and highly precise fit for the patient. By focusing on superior design and technology, ProSomnus aims to deliver an effective therapy with high patient adherence, making it a preferred, non-invasive alternative to CPAP and other traditional sleep apnea solutions, thus securing a growing market share.
Koninklijke Philips N.V.
Koninklijke Philips N.V., or Royal Philips, is a global technology giant with a significant and enduring role in the anti-snoring market through its Connected Care segment, which is centered on sleep and respiratory solutions. The company’s primary contribution is through its portfolio of Continuous Positive Airway Pressure (CPAP) therapy devices and sophisticated patient monitoring platforms. Since Obstructive Sleep Apnea (OSA) is the major cause of chronic snoring, Philips’ CPAP systems are a primary medical treatment for this condition. The company integrates digital health technologies, such as the DreamMapper cloud-based platform, to help users track therapy data and connect with healthcare providers. Philips’ global scale and focus on integrated health technology position it as a critical infrastructure provider in the overall market for sleep-disordered breathing and its associated snoring issues.
SnoreRx
SnoreRx is a prominent and highly-rated brand in the over-the-counter (OTC) anti-snoring device market, known for its effective and user-friendly mandibular advancement device (MAD), the SnoreRx Plus. This mouthpiece is designed to gently move the lower jaw forward to keep the airway open during sleep, thereby reducing or eliminating snoring. The device is favored for its customizability, utilizing a simple boil-and-bite fitting process at home, and offering micro-adjustment settings in one-millimeter increments for personalized comfort and efficacy. SnoreRx operates as a major commercial competitor, providing an accessible and affordable, non-prescription solution. Its focus on combining a custom fit with adjustability has made it a top choice for consumers seeking a convenient, self-managed remedy for habitual snoring.
Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is a U.S.-based key player in the anti-snoring devices and sleep-disordered breathing market, taking an innovative approach to treatment. Vivos focuses on proprietary, non-surgical treatment options for mild-to-moderate Obstructive Sleep Apnea (OSA) and chronic snoring. A notable product is their Daytime-Nighttime Appliance (DNA appliance), which received 510(k) clearance from the US FDA as a Class II medical device. Vivos’s core philosophy is to address the underlying anatomical issue of airway restriction, rather than just providing symptom relief. The company utilizes a network of trained dental and medical professionals to deliver its specialized therapy, positioning its devices as a comprehensive, and potentially permanent, solution for patients seeking alternatives to long-term CPAP use or surgical intervention for their snoring and sleep apnea.
Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a key global company in the anti-snoring devices market, consistently recognized as a major player in market reports due to its specialized focus on respiratory and sleep care products. Though based in New Zealand, its influence is worldwide. The company is a significant provider of hardware, including patient interfaces, humidifiers, and complementary devices for Continuous Positive Airway Pressure (CPAP) therapy. As CPAP remains a gold-standard treatment for Obstructive Sleep Apnea (OSA)—a primary cause of chronic, disruptive snoring—Fisher & Paykel Healthcare’s high-performance and comfortable equipment is central to market operations. The company’s emphasis on mask comfort and usability is crucial for improving patient adherence to CPAP, which in turn drives the adoption of effective, professional-grade anti-snoring solutions globally.
Apnea Sciences
Apnea Sciences is a recognized brand in the anti-snoring devices market, known for its effective and accessible oral appliances, such as the ApneaRx Sleep Apnea Mouthpiece. This company concentrates on developing Mandibular Advancement Devices (MADs) that can be easily custom-fitted at home using a boil-and-bite technique, without requiring a prescription. The ApneaRx device, in particular, is noted for its high degree of adjustability, offering up to 10 different settings, which allows users to find the optimal jaw position for comfort and to maximize the opening of the airway. Apnea Sciences’ strategy focuses on providing a cost-effective, self-managed solution that competes with both generic over-the-counter devices and more expensive custom dental pieces, making effective snoring relief widely available.
ZQuiet
ZQuiet, a brand under Sleeping Well LLC, is a major commercial name in the over-the-counter (OTC) anti-snoring device market. The company specializes in producing easy-to-use and affordable mandibular advancement devices (MADs). ZQuiet’s mouthpiece is engineered to gently move the lower jaw forward, which in turn prevents the airway from collapsing and reduces the throat tissue vibration responsible for snoring. A defining feature of their design is the flexible hinge, which allows users to comfortably open and close their mouth and speak while wearing the device—a significant advantage over many rigid mouthguards. ZQuiet emphasizes convenience, fast delivery, and budget-friendly pricing, positioning it as an ideal, non-invasive entry-point for consumers seeking an immediate solution for simple snoring relief.
Glidewell
Glidewell is a prominent dental laboratory and medical device manufacturer with a strong presence in the anti-snoring and sleep-disordered breathing market, focusing on professional-grade oral appliances. The company is well-known for its custom-fabricated Mandibular Advancement Devices (MADs), notably the Silent Nite® and Silent Nite 3D. These appliances are custom-fitted by dentists, often utilizing advanced technologies like 3D printing and digital impressions to ensure a precise and comfortable fit. Glidewell’s devices are widely prescribed as a primary, non-CPAP treatment option for chronic snoring and mild-to-moderate Obstructive Sleep Apnea (OSA). By catering to the professional dental channel and offering reliable products with strong warranties, Glidewell ensures that high-quality, clinical-grade oral appliance therapy is a widely accessible option for patient treatment.
Latest Market Research Report on Anti-snoring Devices Download PDF Brochure Now